Correlation Between Allogene Therapeutics and Pluri

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Pluri Inc, you can compare the effects of market volatilities on Allogene Therapeutics and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Pluri.

Diversification Opportunities for Allogene Therapeutics and Pluri

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Allogene and Pluri is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Pluri go up and down completely randomly.

Pair Corralation between Allogene Therapeutics and Pluri

Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Pluri. In addition to that, Allogene Therapeutics is 1.02 times more volatile than Pluri Inc. It trades about -0.02 of its total potential returns per unit of risk. Pluri Inc is currently generating about 0.01 per unit of volatility. If you would invest  608.00  in Pluri Inc on August 26, 2024 and sell it today you would lose (118.00) from holding Pluri Inc or give up 19.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Allogene Therapeutics  vs.  Pluri Inc

 Performance 
       Timeline  
Allogene Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allogene Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Pluri Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Allogene Therapeutics and Pluri Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allogene Therapeutics and Pluri

The main advantage of trading using opposite Allogene Therapeutics and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.
The idea behind Allogene Therapeutics and Pluri Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine